Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study

B-cell targeted therapies, such as rituximab (RTX), are used widely in autoimmune rheumatic diseases (AIRD). RTX can cause hypogammaglobulinemia and predispose patients to infections. Herein, we asked whether the underlying diagnosis influences the risk for hypogammaglobulinemia in patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade, Stefanie D., Kyttaris, Vasileios C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019084/
https://www.ncbi.nlm.nih.gov/pubmed/33811499
http://dx.doi.org/10.1007/s00296-021-04847-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019084/
https://www.ncbi.nlm.nih.gov/pubmed/33811499
http://dx.doi.org/10.1007/s00296-021-04847-x

Ejemplares similares